ORBIMED ADVISORS LLC Reduces Stake in Galecto Inc

Published on 27 Jul 2023 on GuruFocus.com via Yahoo Finance

ORBIMED ADVISORS LLC Reduces Stake in Galecto Inc

On July 25, 2023, ORBIMED ADVISORS LLC (Trades, Portfolio), a renowned investment firm, reduced its stake in Galecto Inc, a clinical-stage biotechnology company based in Denmark. This article provides an in-depth analysis of the transaction, the profiles of both ORBIMED ADVISORS LLC (Trades, Portfolio) and Galecto Inc, and the potential implications of this move on their respective portfolios.

Details of the Transaction

Warning! GuruFocus has detected 4 Warning Signs with GLTO. Click here to check it out. GLTO 30-Year Financial DataThe intrinsic value of GLTO

Read the rest of the article

NYSE.HUM price evolution

NASDAQ.GLTO price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

News

ORBIMED ADVISORS LLC Reduces Stake in Galecto Inc

NYSE.HUM price evolution

NASDAQ.GLTO price evolution

Want to become a better investor?

UnitedHealth Pulls Back 11% in 3 Months: Think Twice Before Buying

Jim Cramer on Humana Inc. (HUM): ‘Medicare Provisions Were Much Better Than...

Here's Why it is Prudent for Investors to Hold Humana Stock for Now

Will UNH, HUM & CVS be the Top Beneficiaries of the $21B MA Boom?

Company News for Jan 15, 2025

Humana Inc (NYSE:HUM): A Bullish Investment Perspective

Big Gains Ahead for Medicare Advantage Sellers as Payments Set to Grow

Humana, UnitedHealth, CVS Jump On Potential Medicare Advantage Payment Boost

Humana stock rises on Medicare payment proposal By Investing.com

Zacks Industry Outlook Highlights UnitedHealth, Humana and Centene